Skip to main content
. Author manuscript; available in PMC: 2023 Jul 13.
Published in final edited form as: Cell Host Microbe. 2022 May 13;30(7):1020–1033.e6. doi: 10.1016/j.chom.2022.04.013

Table 1: Risk analysis of broad-spectrum antibiotic pre-exposure in humans.

Adjusted risk ratios for the association between broad-spectrum antibiotic pre-exposure and developing invasive candidiasis (Odds ratio), broad-spectrum antibiotic pre-exposure and 31-day mortality post-invasive Candida infection (hazards ratio), and broad-spectrum antibiotic pre-exposure and developing a systemic bacterial co-infection within 31 days after developing invasive candidiasis (where 31-day mortality was treated as a competing risk, subdistribution hazard ratio). See main text and methods section for total numbers of patients and details of co-variates used. CI, confidence interval.

Clinical variable Adjusted risk ratio Lower CI Upper CI
Invasive candidiasis 1.13 1.03 1.25
Mortality post-invasive candidiasis 1.18 1.02 1.36
Bacterial co-infection, post-invasive candidiasis 1.20 0.90 1.60